study	individual	group	count	intervention	time	time_unit	x_measurement_type	x_substance	x_tissue	x_method	x_label	x	x_sd	x_unit	y_measurement_type	y_substance	y_tissue	y_method	y_label	y	y_sd	y_unit	label	comments
Chen2017b		all	12.0	ED30	0.0	hr	concentration	edoxaban	plasma	LC MS/MS	edoxaban_ED30	0.0		mole/meter^3	aPTT (change)		plasma	coagulation assay	aPTT_change_ED30	0.0		sec	edoxaban_aPTT_change_ED30	
Chen2017b		all	12.0	ED30	1.0	hr	concentration	edoxaban	plasma	LC MS/MS	edoxaban_ED30	0.0002822693948450711	0.0001083826894233822	mole/meter^3	aPTT (change)		plasma	coagulation assay	aPTT_change_ED30	12.0	5.3	sec	edoxaban_aPTT_change_ED30	
Chen2017b		all	12.0	ED30	2.0	hr	concentration	edoxaban	plasma	LC MS/MS	edoxaban_ED30	0.00031711972090545164	7.66342248448157e-06	mole/meter^3	aPTT (change)		plasma	coagulation assay	aPTT_change_ED30	10.9	3.1	sec	edoxaban_aPTT_change_ED30	
Chen2017b		all	12.0	ED30	6.0	hr	concentration	edoxaban	plasma	LC MS/MS	edoxaban_ED30	0.0001853818391484113	5.0542095909557014e-05	mole/meter^3	aPTT (change)		plasma	coagulation assay	aPTT_change_ED30	5.9	2.0	sec	edoxaban_aPTT_change_ED30	
Chen2017b		all	12.0	ED30	12.0	hr	concentration	edoxaban	plasma	LC MS/MS	edoxaban_ED30	8.06483985271632e-05	3.904696218283466e-05	mole/meter^3	aPTT (change)		plasma	coagulation assay	aPTT_change_ED30	1.0	1.4	sec	edoxaban_aPTT_change_ED30	
Chen2017b		all	12.0	ED30	24.0	hr	concentration	edoxaban	plasma	LC MS/MS	edoxaban_ED30	3.393801385984695e-05	2.4267504534191637e-05	mole/meter^3	aPTT (change)		plasma	coagulation assay	aPTT_change_ED30	0.7	0.8	sec	edoxaban_aPTT_change_ED30	
